Ustekinumab
IL-12/23 antibody for psoriasis and inflammatory bowel disease.
- Starts working
- Weeks
- Half-life
- About 3 weeks
- In use since
- —
- Pregnancy
- Use with caution
Overview
Ustekinumab blocks the shared p40 unit of IL-12 and IL-23. It is injected every 8–12 weeks and is used for plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
Conditions it's used for
How it works
Blocks inflammation signals IL-12 and IL-23.
Ustekinumab belongs to the Interleukin inhibitors. How Interleukin inhibitors work: block one specific immune messenger that drives a particular disease.
Uses
- Plaque psoriasis
- Psoriatic arthritis
- Crohn's disease
- Ulcerative colitis
Available as: subcutaneous injection, iv infusion (induction).
Typical dose
- Adults
- 45–90 mg subcutaneously at weeks 0 and 4 then every 12 weeks (psoriasis); IV induction in IBD.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Upper respiratory infections
- Headache
- Tiredness
- Injection site redness
Serious — get medical help
Uncommon, but need prompt attention
- Serious infections
- Allergic reactions
- Reversible leukoencephalopathy (rare)
Warnings
- Screen for TB before starting
Who should avoid it
- Active serious infection
- Active TB
Interactions
- Live vaccines — avoid
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Inject when remembered, then continue as scheduled.
- Stopping it
- Only on advice of your specialist.
- Driving
- No effect.
- Tests and checks
- Infection symptoms; TB screening
- If too much is taken
- No specific antidote.
- Storage
- Refrigerate.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data; may be continued when benefit outweighs risk.
Breastfeeding
Use with caution
Limited data.
Special groups
- Kidney disease
- No adjustment.
- Liver disease
- No adjustment.
- Older adults
- Higher infection risk.
Brand names
- United States
- Stelara, Wezlana
- United Kingdom
- Stelara, Wezenla
- India
- Stelara, Ustekinumab biosimilars
- Australia
- Stelara
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Ustekinumab?
Yes — Ustekinumab is prescription-only in most countries.
Can I take Ustekinumab during pregnancy?
Use with caution. Limited data; may be continued when benefit outweighs risk. Always check with a doctor or midwife.
How quickly does Ustekinumab work?
Weeks.
Related medicines
Adalimumab
Biologic injection for arthritis, IBD and psoriasis.
RxTNF inhibitorsSecukinumab
Biologic for psoriasis and spondyloarthritis.
RxInterleukin inhibitorsInfliximab
IV anti-TNF biologic for Crohn's and arthritis.
RxTNF inhibitorsDupilumab
Biologic injection for severe eczema and asthma.
RxInterleukin inhibitorsIxekizumab
IL-17A antibody for psoriasis and spondyloarthritis.
RxInterleukin inhibitorsTocilizumab
IL-6 receptor antibody for rheumatoid arthritis, giant cell arteritis and cytokine storm.
RxWHOInterleukin inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L04AC05
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.